Thomas A. Abrams
- Oncology top 2%
- Colorectal Cancer Treatments and Studies 30
- Pancreatic and Hepatic Oncology Research 17
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis 19
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 7
-
- Gastric Cancer Management and Outcomes 16
- Lung Cancer Treatments and Mutations 14
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 19
-
- Neuroendocrine Tumor Research Advances 8
- Co-authors
- Charles S. FuchsJeffrey A. MeyerhardtAndrew X. ZhuLawrence S. BlaszkowskyDavid P. RyanDeborah SchragBrian M. WolpinPeter C. Enzinger
- Cited by
- OncologyHepatologyCancer Research
- Journals
- Journal of Clinical Oncology (45 papers)Annals of Oncology (5 papers)Investigational New Drugs (4 papers)
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Thomas A. Abrams
81 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 97
- Oncology 1.4k
- Hepatology 344
- Cancer Research 354
- Pulmonary and Respiratory Medicine 668
- Pathology and Forensic Medicine 367
Countries citing papers authored by Thomas A. Abrams
This map shows the geographic impact of Thomas A. Abrams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas A. Abrams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas A. Abrams more than expected).
Fields of papers citing papers by Thomas A. Abrams
This network shows the impact of papers produced by Thomas A. Abrams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas A. Abrams. The network helps show where Thomas A. Abrams may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Thomas A. Abrams, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 3 | |
| 4 | 2022 | 20 | |
| 5 | 2021 | 4 | |
| 6 | 2021 | 4 | |
| 7 | 2020 | 31 | |
| 8 | 2020 | 46 | |
| 9 | 2020 | 8 | |
| 10 | 2018 | 17 | |
| 11 | 2016 | 4 | |
| 12 | 2014 | 120 | |
| 13 | 2014 | 42 | |
| 14 | 2014 | 82 | |
| 15 | 2013 | 38 | |
| 16 | 2013 | 55 | |
| 17 | 2011 | 83 | |
| 18 | 2011 | 163 | |
| 19 | 2011 | 6 | |
| 20 | 2010 | 76 |
About Thomas A. Abrams
Thomas A. Abrams is a scholar working on Hepatology, Oncology and Pulmonary and Respiratory Medicine, having authored 84 papers that have together received 2.4k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (30 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (19 papers), Hepatocellular Carcinoma Treatment and Prognosis (19 papers), Pancreatic and Hepatic Oncology Research (17 papers), Gastric Cancer Management and Outcomes (16 papers), Lung Cancer Treatments and Mutations (14 papers), Neuroendocrine Tumor Research Advances (8 papers) and Cancer Genomics and Diagnostics (7 papers). The work is most often cited by research in Oncology (1.4k citations), Hepatology (344 citations) and Cancer Research (354 citations). Thomas A. Abrams has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Charles S. Fuchs, Jeffrey A. Meyerhardt, Andrew X. Zhu, Lawrence S. Blaszkowsky, David P. Ryan, Deborah Schrag, Brian M. Wolpin, Peter C. Enzinger, Jennifer A. Chan and Jeffrey W. Clark. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Investigational New Drugs, The Oncologist and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.